Vir Biotechnology, Inc. (VIR)
About Vir Biotechnology, Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $68.6M
- Net income
- -$438.0M
- Total assets
- $1.0B
- Market cap
- $1.5B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.5B
- Dividend yield
- 0.95%
- Shares outstanding
- 138.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 11, 2019
Vir Biotechnology, Inc. (VIR) Stock Price
- Reported a net loss of $438.0M in FY2025.
- Trading 10% below its 52-week high.
- Pays a dividend yielding about 0.95% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Vir Biotechnology, Inc..
Write a review
News about Vir Biotechnology, Inc.
News & sentiment via Polygon.io
Vir Biotechnology, Inc.: frequently asked questions
Is Vir Biotechnology, Inc. an American company?
Vir Biotechnology, Inc. is a US-based company headquartered in San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Vir Biotechnology, Inc. headquartered?
Vir Biotechnology, Inc. is headquartered in San Francisco, California, United States.
Is Vir Biotechnology, Inc. publicly traded?
Yes — Vir Biotechnology, Inc. is a publicly traded company. Its stock trades under the ticker symbol VIR on the NASDAQ.
What does Vir Biotechnology, Inc. do?
Vir Biotechnology, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
When was Vir Biotechnology, Inc. founded?
Vir Biotechnology, Inc. was founded in 2016.
